Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Universal Health Realty Income Trust (UHT) Cost of Revenue (2016 - 2026)

Universal Health Realty Income Trust has reported Cost of Revenue over the past 16 years, most recently at $7.4 million for Q4 2025.

  • Quarterly Cost of Revenue rose 3.33% to $7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.0 million through Dec 2025, up 2.25% year-over-year, with the annual reading at $30.0 million for FY2025, 2.25% up from the prior year.
  • Cost of Revenue was $7.4 million for Q4 2025 at Universal Health Realty Income Trust, down from $7.6 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $8.2 million in Q2 2023 and troughed at $5.6 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $7.4 million (2025), against an average of $7.1 million.
  • Year-over-year, Cost of Revenue grew 27.22% in 2022 and then dropped 15.45% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $6.0 million in 2021, then grew by 27.22% to $7.6 million in 2022, then decreased by 0.42% to $7.5 million in 2023, then dropped by 4.6% to $7.2 million in 2024, then rose by 3.33% to $7.4 million in 2025.
  • Per Business Quant, the three most recent readings for UHT's Cost of Revenue are $7.4 million (Q4 2025), $7.6 million (Q3 2025), and $7.6 million (Q2 2025).